Multimodal therapy including neoadjuvant methotrexate, vinblastine, doxorubicin, and cisplatin (MVAC) for stage IIB to IV cervical cancer

American Journal of Obstetrics and Gynecology

Volumn 186, Issue 6, 2002, Pages 1167-1173

  Dowdy, Sean C ^a   Boardman, Cecelia H ^a   Wilson, Timothy O ^a   Podratz, Karl C ^a   Hartmann, Lynn C ^a   Long, Harry J ^a  

^a MAYO CLINIC   (United States)

Author keywords

Cervical cancer; Chemotherapy; Neoadjuvant

Indexed keywords

CISPLATIN; DOXORUBICIN; METHOTREXATE; VINBLASTINE;

ADJUVANT CHEMOTHERAPY; ADULT; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; FEMALE; HISTOLOGY; HUMAN; HUMAN TISSUE; LEUKOPENIA; NEUROTOXICITY; NEUTROPENIA; PRIORITY JOURNAL; STOMATITIS; SURVIVAL RATE; THROMBOCYTOPENIA; TREATMENT OUTCOME; UTERINE CERVIX CANCER;

EID: 0036081937     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1067/mob.2002.123820     Document Type: Conference Paper

References (15)

1. Cancer statistics, 2000
2. Global cancer statistics
3. Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer
4. Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer
5. Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma
6. Chemotherapy of gynecologic cancer
7. Chemotherapy of cervical carcinoma
8. The role of chemotherapy in squamous cell carcinoma of the uterine cervix: A review
9. Combination bleomycin, ifosfamide, and cisplatin chemotherapy in cervical cancer
10. Phase II trial of methotrexate, vinblastine, doxorubicin, and cisplatin in advanced/recurrent carcinoma of the uterine cervix and vagina
11. MVAC: A highly active combination chemotherapy regimen in advanced/recurrent cancer of the uterine cervix and vagina
12. A phase II trial of methotrexate, vinblastine, doxorubicin, and cisplatin in the treatment of metastatic carcinoma of the uterine cervix
13. Neoadjuvant MVAC (methotrexate, vinblastine, doxorubicin, cisplatin) chemotherapy for locally advanced or metastatic cervical and vaginal cancer
14. Adenocarcinoma of the uterine cervix: Prognosis and patterns of failure in 367 cases
15. Irradiation alone or combined with surgery in stage IB, IIA, and IIB carcinoma of uterine cervix: Update of a non-randomized comparison